Schizophrenia medication adherence in a resource-poor setting: Randomised controlled trial of supervised treatment in out-patients for schizophrenia (STOPS)

British Journal of Psychiatry

Volumn 199, Issue 6, 2011, Pages 467-472

  Farooq, Saeed ^a,b   Nazar, Zahid ^b   Irfan, Muhammad ^b   Akhter, Javed ^c   Gul, Ejaz ^b   Irfan, Uma ^d   Naeem, Farooq ^e  

^a STAFFORDSHIRE UNIVERSITY   (United Kingdom)

^b LADY READING HOSPITAL   (Pakistan)

^c Bannu Medical College   (Pakistan)

^d KHYBER MEDICAL UNIVERSITY   (Pakistan)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PATIENT COMPLIANCE; PATIENT MONITORING; POSITIVE AND NEGATIVE SYNDROME SCALE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AMBULATORY CARE; ANTIPSYCHOTIC AGENTS; CAREGIVERS; DEVELOPING COUNTRIES; FEMALE; HUMANS; INTENTION TO TREAT ANALYSIS; LONG-TERM CARE; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PAKISTAN; PROGRAM EVALUATION; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 83455236458     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.110.085340     Document Type: Article

References (30)

1. Murray CJL, Lopez AD. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and projected to 2020. Harvard School of Public Health, 1996.
2. The Academy of Medical Sciences. Challenges and Priorities for Global Mental Health Research in Low and Middle Income Countries: Symposium Report: 10-1. Academy of Medical Sciences, 2008.
3. World Health Organization. Mental Health Atlas 2005. WHO, 2005 (http://www.who.int/mental-health/evidence/mhatlas05/en/index.html).
4. Farooq S, Large M, Nielssen O, Waheed W. The relationship between the duration of untreated psychosis and outcome in low-and-middle income countries: a systematic review and meta analysis. Schizophr Res 2009; 109: 15-23.
5. Mari JDJ, Razzouk D, Thara R, Eaton J, Thornicroft G. Packages of care for schizophrenia in low- and middle-income countries. PLoS Med 2009; 6: e1000165.
6. Babiker IE. Noncompliance in schizophrenia. Psychiatr Dev 1986; 4: 329-37. (Pubitemid 17031945)
7. Weiden PJ, Olfson M. Cost of relapse in schizophrenia. Schizophr Bull 1995; 21: 419-29.
8. Zygmunt A, Olfson M, Boyer CA, Mechanic D. The interventions to improve medication adherence in schizophrenia. Am J Psychiatry 2002; 159: 1653-64.
9. Patel V, Farooq S, Thara R. What is the best approach to treating schizophrenia in developing countries? PLoS Med 2007; 4: e159.
10. Leiberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005; 353: 1209-23. (Pubitemid 41345943)
11. Farooq S, Nazar Z, Akhter J, Irfan M, Naeem S. From DOTS to STOPS - public health intervention for schizophrenia in low and middle income countries. J Pak Psych Soc 2008; 5: 68-71.
12. World Health Organization. Global Tuberculosis Control-Surveillance, Planning, Financing. WHO, 2007 (http://www.who.int/tb/publications/global- report/2007/en/).
13. American Psychiatric Association. Practice Guideline for the Treatment of Patients with Schizophrenia (2nd edn): 114-7. APA, 2004.
14. American Psychiatric Association. Global Assessment of Functioning (GAF) Scale. Diagnostic and Statistical Manual of Mental Disorders (4th edn): 32. APA, 2000.
15. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. WHO, 1993.
16. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13: 261-76. (Pubitemid 18039085)
17. Herz MI, Lamberti S, Mintz J, Scott R, O'Dell SP, McCartan L, et al. A program for relapse prevention in schizophrenia. A controlled study. Arch Gen Psychiatry 2000; 57: 277-83. (Pubitemid 30140437)
18. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001; 357: 1191-4. (Pubitemid 32378696)
19. British Medical Association and Royal Pharmaceutical Society. British National Formulary 57. BMJ Publishing Group and Royal Pharmaceutical Society, 2009.
20. Harries AD, Jahn A, Zachariah R, Enarson D. Adapting the DOTS framework for tuberculosis control to the management of non-communicable diseases in sub-Saharan Africa. PLoS Med 2008; 5: e124.
21. Li Z, Arthur D. Family education for people with schizophrenia in Beijing, China; randomised controlled trial. Br J Psychiatry 2005; 187: 339-45. (Pubitemid 41442386)
22. Xiong W, Phillips MR, Hu X, Wang R, Dai Q, Kleinman J, et al. Family-based intervention for schizophrenic patients in China: a randomised controlled trial. Br J Psychiatry 1994; 165: 239-47. (Pubitemid 24259351)
23. Jacob KS. Community care for people with mental disorders in developing countries. Problems and possible solutions. Br J Psychiatry 2001; 178: 296-8. (Pubitemid 32280921)
24. Qui F, Lu S. Guardianship networks for rural psychiatric patients. A non-professional support system in Jinshan County, Shanghai, Br J Psychiatry 1994; 165 (suppl 24): 114-20. (Pubitemid 24259377)
25. Murthy RS, Kishore KVK, Chisolm D, Thomas T, Seskar K, Chandrashekar CR. Community outreach for untreated schizophrenia in rural India: a follow-up study of symptoms, disability, family burden and costs. Psychol Med 2005; 35: 341-51. (Pubitemid 40372473)
26. Chatterjee S, Patel V, Chatterjee A, Weis HA. Evaluation of community-based rehabilitation model for chronic schizophrenia in rural India. Br J Psychiatry 2003; 182: 57-62. (Pubitemid 36132420)
27. Doshi JA, Zhu J, Lee BY, Kimmel S, Volpp KG. Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans. Circulation 2009; 119: 390-7.
28. Burns T, Priebe S. Mental health care systems and their characteristics: a proposal. Acta Psychiatr Scand 1996; 94: 381-5. (Pubitemid 27028797)
29. Harrison G, Hooper K, Craig T, Laska E, Siegel C, Waderling J, et al. Recovery from psychotic illness: a 15- and 25-year international follow-up study. Br J Psychiatry 2001; 178: 506-17. (Pubitemid 32531743)
30. Weiden PJ, Kozma C, Grogg A, Locklear J. Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatr Serv 2004; 55: 886-91. (Pubitemid 39025215)